Clinical Trial Update: TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and antiviral activity of etravirine (TMC125) in treatment-experienced HIV-infected children and adolescents; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Intelence (Etravirine)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV-1 | Phase 2 | Status: COMPLETED | Results posted: 2012-12-21